NCT01559727View on ClinicalTrials.gov

Dose-comparison Study of Prednisone in Heart Failure

PHASE3CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

March 31, 2012

Primary Completion Date

January 31, 2013

Study Completion Date

March 31, 2013

Conditions
Heart Failure
Interventions
DRUG

prednisone

The patients with symptomatic heart failure are treated with prednisone at dose of 15 mg/day.

DRUG

prednisone

The patients with symptomatic heart failure are treated with prednisone at dose of 30 mg/day

DRUG

prednisone

The patients with symptomatic heart failure are treated with prednisone at dose of 60 mg/day

Trial Locations (2)

050031

The First Hospital of Hebei Medical University, Shijiazhuang

The First Hospital of Hebei Medical University, Shijiazhuang

All Listed Sponsors
lead

Hebei Medical University

OTHER

NCT01559727 - Dose-comparison Study of Prednisone in Heart Failure | Biotech Hunter | Biotech Hunter